AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32544561 — intervention group
Group type: COMPARATOR
Intervention: Pro re nata (PRN) regimen
Number of subjects: 264
Study 36361237 — intervention group
Group type: EXPERIMENTAL
Intervention: OFA combined with a paravertebral block with 0.5% bupivacaine
Number of subjects: 50
Study 36361237 — intervention group
Group type: COMPARATOR
Intervention: Typical general anaesthesia with opioids
Number of subjects: 50
Study 32653604 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine injection (0.5 %, 5 mg/mL) at a dose of 4 ml for the umbilicus and 2 ml for each 5‐mm ancillary trocar site
Number of subjects: 108
Study 32653604 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine injection (0.5 %, 5 mg/mL)
Number of subjects: 108
Study 32653604 — intervention group
Group type: COMPARATOR
Intervention: Control group (no bupivacaine administered)
Number of subjects: 108
Study 35007962 — intervention group
Group type: EXPERIMENTAL
Intervention: Tuning in to Toddlers (TOTS) parenting program
Number of subjects: 300
Study 35803290 — intervention group
Group type: EXPERIMENTAL
Intervention: CAS + IMD (1200 mg subcutaneous injection)
Number of subjects: 2317
Study 35803290 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2317
Study 35803290 — intervention group
Group type: EXPERIMENTAL
Intervention: CAS + IMD
Number of subjects: 2317
Study 34423033 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (3 mg per day for 12 weeks)
Number of subjects: 38
Study 34423033 — intervention group
Group type: COMPARATOR
Intervention: Placebo (3 mg per day for 12 weeks)
Number of subjects: 38
Study 36314057 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 12 mg daily
Number of subjects: 0
Study 36314057 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone 6 mg daily
Number of subjects: 0
Study 33434852 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS (2 mA, n = 15)
Number of subjects: 30
Study 33434852 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS (n = 15)
Number of subjects: 30
Study 36334724 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal seeding (n=60; swabbed with gauze preincubated in maternal vagina)
Number of subjects: 120
Study 36334724 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal seeding (n=60)
Number of subjects: 120
Study 36334724 — intervention group
Group type: COMPARATOR
Intervention: Control (n=60; routine standard care)
Number of subjects: 120
Study 36334724 — intervention group
Group type: COMPARATOR
Intervention: Control (n=60)
Number of subjects: 120
Study 34622872 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture plus Tramadol
Number of subjects: 0
Study 34622872 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture plus Tramadol
Number of subjects: 0
Study 34506086 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete decongestive therapy (CDT)
Number of subjects: 40
Study 34506086 — intervention group
Group type: COMPARATOR
Intervention: Kinesiology taping (KT)
Number of subjects: 40
Study 36343727 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive task (Stroop test)
Number of subjects: 20
Study 36343727 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep breathing
Number of subjects: 20
Study 36343727 — intervention group
Group type: EXPERIMENTAL
Intervention: Static stretching
Number of subjects: 20
Study 36343727 — intervention group
Group type: COMPARATOR
Intervention: No-task
Number of subjects: 20
Study 34269256 — intervention group
Group type: EXPERIMENTAL
Intervention: APRV
Number of subjects: 90
Study 34269256 — intervention group
Group type: COMPARATOR
Intervention: SIMV-PC(P)
Number of subjects: 90
Study 34269256 — intervention group
Group type: COMPARATOR
Intervention: SIMV-VC(V)
Number of subjects: 90
Study 32310911 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin (EPO)
Number of subjects: 60
Study 32310911 — intervention group
Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 60
Study 35249115 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram-based blunt thoracic aortic injury screening model
Number of subjects: 305141
Study 35249115 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivariate analysis in the training cohort
Number of subjects: 305141
Study 34450188 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride
Number of subjects: 18667
Study 34450188 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18667
Study 33560163 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial prophylaxis (211 patients)
Number of subjects: 474
Study 33560163 — intervention group
Group type: COMPARATOR
Intervention: No antimicrobial prophylaxis (263 patients)
Number of subjects: 474
Study 32503093 — intervention group
Group type: EXPERIMENTAL
Intervention: Ocrelizumab (OCR) 600 mg administered over a 2-hour infusion
Number of subjects: 580
Study 32503093 — intervention group
Group type: COMPARATOR
Intervention: Ocrelizumab (OCR) 600 mg administered over a 3.5-hour infusion (conventional)
Number of subjects: 580
Study 34525259 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus-facilitated reduced-exposure tacrolimus (EVR + rTAC)
Number of subjects: 333
Study 34525259 — intervention group
Group type: COMPARATOR
Intervention: Standard-exposure tacrolimus (sTAC)
Number of subjects: 333
Study 33106280 — intervention group
Group type: EXPERIMENTAL
Intervention: Transmuscular quadratus lumborum (TQL) block with ropivacaine 60 mL 0.375%
Number of subjects: 50
Study 33106280 — intervention group
Group type: COMPARATOR
Intervention: Control group (saline 60 mL)
Number of subjects: 50
Study 33050920 — intervention group
Group type: EXPERIMENTAL
Intervention: IMRT with SIB (Arm A: whole breast 28 × 1.8 Gy, Boost 28 × 2.3 Gy)
Number of subjects: 446
Study 33050920 — intervention group
Group type: COMPARATOR
Intervention: 3D-conformal radiotherapy with sequential boost (Arm B: whole breast 28 × 1.8 Gy, boost 8 × 2 Gy)
Number of subjects: 446
Study 33813942 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental spelling training
Number of subjects: 108
Study 33813942 — intervention group
Group type: COMPARATOR
Intervention: Waiting list condition (Control)
Number of subjects: 108
Study 35144954 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepped palliative care (PC) model, visits at clinically significant points unless QOL decreases, then every 4 weeks
Number of subjects: 510
Study 35144954 — intervention group
Group type: COMPARATOR
Intervention: Early integrated palliative care (PC) model, visits every 4 weeks throughout illness
Number of subjects: 510
Study 35144954 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepped palliative care (PC) model
Number of subjects: 510
Study 32694372 — intervention group
Group type: EXPERIMENTAL
Intervention: BFR walking (200 mm Hg pressure cuffs, 5 km·h, 5 sets of 2-min walking with 1-min rest intervals)
Number of subjects: 24
Study 32694372 — intervention group
Group type: COMPARATOR
Intervention: NBFR walking (no pressure cuffs, same walking protocol)
Number of subjects: 24
Study 35110385 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician judgement
Number of subjects: 4533
Study 35110385 — intervention group
Group type: COMPARATOR
Intervention: Diamond‐Forrester (D‐F) estimates
Number of subjects: 4533
Study 35110385 — intervention group
Group type: COMPARATOR
Intervention: European Society of Cardiology (ESC) estimates
Number of subjects: 4533
Study 34781936 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone health coaching (THC) sessions (monthly, average 30 min for 12 months)
Number of subjects: 1535
Study 34781936 — intervention group
Group type: COMPARATOR
Intervention: Usual health care services
Number of subjects: 1535
Study 34781936 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone health coaching (THC)
Number of subjects: 1535
Study 32857785 — intervention group
Group type: EXPERIMENTAL
Intervention: GoActive intervention
Number of subjects: 0
Study 32857785 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 35180445 — intervention group
Group type: EXPERIMENTAL
Intervention: Synchronous stroking
Number of subjects: 82
Study 35180445 — intervention group
Group type: COMPARATOR
Intervention: Asynchronous stroking (control condition)
Number of subjects: 82
Study 34521963 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention for 30 minutes applied by a nurse
Number of subjects: 58
Study 34521963 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 58
Study 34922724 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol (75 mg) + Dexketoprofen (25 mg)
Number of subjects: 72
Study 34922724 — intervention group
Group type: COMPARATOR
Intervention: Ibuprofen (400 mg)
Number of subjects: 72
Study 32663980 — intervention group
Group type: EXPERIMENTAL
Intervention: Real repetitive transcranial magnetic stimulation (rTMS)
Number of subjects: 60
Study 32663980 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 60
Study 32663980 — intervention group
Group type: COMPARATOR
Intervention: Normal controls (NCs)
Number of subjects: 60
Study 35026038 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based brief intervention program for recording daily alcohol consumption for 4 weeks
Number of subjects: 100
Study 35026038 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 100
Study 33475224 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthcare provider advice that it is acceptable to continue to smoke cigarettes in small amounts
Number of subjects: 217
Study 33475224 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived harm reduction of smoking light cigarettes
Number of subjects: 217
Study 33475224 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate to severe depression and anxiety score
Number of subjects: 217
Study 33245865 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-delivered psychosocial intervention
Number of subjects: 0
Study 33245865 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 33075775 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride dentifrice with 5,000 µg F/g
Number of subjects: 10
Study 33075775 — intervention group
Group type: COMPARATOR
Intervention: Fluoride dentifrice with 1,300 µg F/g
Number of subjects: 10
Study 33075775 — intervention group
Group type: COMPARATOR
Intervention: Fluoride dentifrice with 0 µg F/g
Number of subjects: 10
Study 33075775 — intervention group
Group type: COMPARATOR
Intervention: Fluoride dentifrice with 700 µg F/g
Number of subjects: 10
Study 32522095 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor (loading dose: 180 mg, maintenance dose: 90 mg bid)
Number of subjects: 114
Study 32522095 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel (loading dose: 300 mg, maintenance dose: 75 mg qd)
Number of subjects: 114
Study 32522095 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 114
Study 32522095 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 114
Study 33234951 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper blepharoplasty (conventional skin excision techniques)
Number of subjects: 316
Study 34593298 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmon calcitonin nasal spray
Number of subjects: 14
Study 34593298 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 14
Study 35108610 — intervention group
Group type: EXPERIMENTAL
Intervention: EFV 400 mg
Number of subjects: 420
Study 35436807 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced MRI nomogram model
Number of subjects: 116
Study 35436807 — intervention group
Group type: COMPARATOR
Intervention: Rim arterial phase hyperenhancement
Number of subjects: 116
Study 35436807 — intervention group
Group type: EXPERIMENTAL
Intervention: Rim arterial phase hyperenhancement and enhanced capsule
Number of subjects: 116
Study 33186308 — intervention group
Group type: EXPERIMENTAL
Intervention: Intercostal nerve block using 10 ml 0.35% ropivacaine (group MINB)
Number of subjects: 50
Study 33186308 — intervention group
Group type: COMPARATOR
Intervention: Conventional general anaesthesia (group CGA)
Number of subjects: 50
Study 33186308 — intervention group
Group type: EXPERIMENTAL
Intervention: Intercostal nerve block (group MINB)
Number of subjects: 50
Study 36417295 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive video portrayal
Number of subjects: 82
Study 36417295 — intervention group
Group type: COMPARATOR
Intervention: Negative video portrayal
Number of subjects: 82
Study 34411275 — intervention group
Group type: EXPERIMENTAL
Intervention: Bundled care program including povidone-iodine skin preparation, nasal decolonization, iodine-alcohol surgical prepping solution, iodophor-impregnated incise drapes, forced-air warming blankets, and negative pressure wound therapy.
Number of subjects: 0
Study 34411275 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 32881945 — intervention group
Group type: EXPERIMENTAL
Intervention: Complementary feeding behavior change communication for 9 months
Number of subjects: 0
Study 35653595 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined bleaching (desensitizing gel for 10 minutes, in-office bleaching with 35% hydrogen peroxide for 2×15 minutes, followed by at-home bleaching with 4% hydrogen peroxide for 2×30 minutes for 21 days)
Number of subjects: 80
Study 35653595 — intervention group
Group type: COMPARATOR
Intervention: At-home bleaching (4% hydrogen peroxide for 2×30 minutes for 21 days)
Number of subjects: 80
Study 33596587 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported sensitivity to reward (SR) in BD + AD group
Number of subjects: 100
Study 33596587 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported sensitivity to punishment (SP) in all clinical groups
Number of subjects: 100
Study 33596587 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral response times
Number of subjects: 100
Study 34666346 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal anesthesia with targeted sedation based on BIS values (BIS 60 to 70)
Number of subjects: 217
Study 33556013 — intervention group
Group type: EXPERIMENTAL
Intervention: Thigh phase angle parameterization
Number of subjects: 10
Study 33556013 — intervention group
Group type: EXPERIMENTAL
Intervention: Tibia phase angle parameterization
Number of subjects: 10
Study 33556013 — intervention group
Group type: COMPARATOR
Intervention: Time parameterization
Number of subjects: 10
Study 33438669 — intervention group
Group type: EXPERIMENTAL
Intervention: Real neurofeedback (direct transform of their motor imagery-related brain activity)
Number of subjects: 28
Study 33438669 — intervention group
Group type: COMPARATOR
Intervention: Sham feedback (related to someone else's brain activity)
Number of subjects: 28
Study 34839398 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention Group (IG) underwent a mean negative energy balance of 270 (289) kcal/day, p < 0.001, resulting in a weight loss of -4.8 (4.9)% and fat mass loss of -11.3 (10.8)%. AT occurred in the IG, ranging from -65 to -230 kcal/day.
Number of subjects: 94
Study 34839398 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG) showed significant AT in three approaches.
Number of subjects: 94
Study 34398083 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid-based dermal fillers
Number of subjects: 35
Study 32729099 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 600 mg/bid from 48 hours before to 24 hours after the procedure with fixed maximal voltage (Group C)
Number of subjects: 164
Study 32729099 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepwise ramping voltage of ESWL (Group B)
Number of subjects: 164
Study 32729099 — intervention group
Group type: EXPERIMENTAL
Intervention: Gradual ramping voltage with NAC (Group D)
Number of subjects: 164
Study 32729099 — intervention group
Group type: COMPARATOR
Intervention: Maximal fixed voltage of ESWL (Group A)
Number of subjects: 164
Study 32729099 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 164
Study 35798513 — intervention group
Group type: EXPERIMENTAL
Intervention: Full intervention package (school meals, school gardens, nutrition education, community workshops)
Number of subjects: 750
Study 35798513 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial intervention package (school garden, nutrition education, community workshops)
Number of subjects: 750
Study 35798513 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 750
Study 34247394 — intervention group
Group type: EXPERIMENTAL
Intervention: Sit-to-stand training plus routine physiotherapy
Number of subjects: 38
Study 34247394 — intervention group
Group type: COMPARATOR
Intervention: Routine physiotherapy only
Number of subjects: 38
Study 32812316 — intervention group
Group type: EXPERIMENTAL
Intervention: WeChat group
Number of subjects: 0
Study 32812316 — intervention group
Group type: COMPARATOR
Intervention: Telephone group
Number of subjects: 0
Study 35716457 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline (PTX) added to ibuprofen + paracetamol + pregabalin
Number of subjects: 58
Study 35716457 — intervention group
Group type: COMPARATOR
Intervention: No Pentoxifylline (Control) with ibuprofen + paracetamol + pregabalin
Number of subjects: 58
Study 32638858 — intervention group
Group type: COMPARATOR
Intervention: Positive control diet - without phytase or xylanase
Number of subjects: 250
Study 32638858 — intervention group
Group type: COMPARATOR
Intervention: Negative control diet - with an energy reduction of 100 kcal/kg, without phytase or xylanase
Number of subjects: 250
Study 32638858 — intervention group
Group type: EXPERIMENTAL
Intervention: Diets containing xylanase and phytase with energy reductions of 50, 100, and 150 Kcal/kg
Number of subjects: 250
Study 34013489 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Relapse Prevention (MBRP) program
Number of subjects: 70
Study 34013489 — intervention group
Group type: COMPARATOR
Intervention: Weekly phone monitoring only (Control Group)
Number of subjects: 70
Study 33988155 — intervention group
Group type: EXPERIMENTAL
Intervention: Pethidine 50 mg intramuscular injection
Number of subjects: 194
Study 33988155 — intervention group
Group type: COMPARATOR
Intervention: Placebo injection
Number of subjects: 194
Study 34435269 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive, online educational video
Number of subjects: 0
Study 34435269 — intervention group
Group type: COMPARATOR
Intervention: Standard verbal and written instructions
Number of subjects: 0
Study 34022364 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-part PHF with LLP and RC cerclage
Number of subjects: 27
Study 34022364 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-part PHF with LLP, RC cerclage, and 2 anterior 3.5-mm cortical screws
Number of subjects: 27
Study 34022364 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-part PHF with LLP, RC cerclage, and additional anterior one-third tubular plate (AAP)
Number of subjects: 27
Study 34022364 — intervention group
Group type: COMPARATOR
Intervention: 4-part PHF with LLP and RC cerclage as standard of care
Number of subjects: 27
Study 34181300 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation (tDCS) over the primary motor cortex (M1)
Number of subjects: 0
Study 34181300 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation (control)
Number of subjects: 0
Study 32156788 — intervention group
Group type: EXPERIMENTAL
Intervention: NAVA low (5 cm H2O)
Number of subjects: 8
Study 32156788 — intervention group
Group type: EXPERIMENTAL
Intervention: NAVA high (15 cm H2O)
Number of subjects: 8
Study 32156788 — intervention group
Group type: COMPARATOR
Intervention: PSV low (5 cm H2O)
Number of subjects: 8
Study 32156788 — intervention group
Group type: COMPARATOR
Intervention: PSV high (15 cm H2O)
Number of subjects: 8
Study 34251533 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation (PBM) treatment (660 nm, 100mW, 177 J/cm2, 5 s, 0.5 J) twice a week for 30 days
Number of subjects: 0
Study 34251533 — intervention group
Group type: COMPARATOR
Intervention: Clobetasol propionate 0.05% (corticosteroid)
Number of subjects: 0
Study 33592310 — intervention group
Group type: EXPERIMENTAL
Intervention: ICUconnect intervention
Number of subjects: 160
Study 33592310 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 160
Study 32241164 — intervention group
Group type: EXPERIMENTAL
Intervention: Tooth brushing
Number of subjects: 2435
Study 32241164 — intervention group
Group type: COMPARATOR
Intervention: No tooth brushing
Number of subjects: 2435
Study 32241164 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe gingivitis
Number of subjects: 2435
Study 32241164 — intervention group
Group type: COMPARATOR
Intervention: Healthy periodontium
Number of subjects: 2435
Study 32241164 — intervention group
Group type: EXPERIMENTAL
Intervention: Gender (female)
Number of subjects: 2435
Study 32241164 — intervention group
Group type: COMPARATOR
Intervention: Gender (male)
Number of subjects: 2435
Study 32241164 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate gingivitis
Number of subjects: 2435
Study 32241164 — intervention group
Group type: EXPERIMENTAL
Intervention: Slight gingivitis
Number of subjects: 2435
Study 34919073 — intervention group
Group type: EXPERIMENTAL
Intervention: VK2+VD3 group (received vitamin K2, vitamin D3, and calcium treatment)
Number of subjects: 78
Study 34919073 — intervention group
Group type: COMPARATOR
Intervention: Control group (received only calcium and vitamin D3)
Number of subjects: 78
Study 34919073 — intervention group
Group type: EXPERIMENTAL
Intervention: VK2+VD3 group
Number of subjects: 78
Study 34919073 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 78
Study 33406130 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Scouts intervention (community health worker-delivered, theory-based counseling strategy)
Number of subjects: 2148
Study 33406130 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 2148
Study 36069950 — intervention group
Group type: EXPERIMENTAL
Intervention: add-on alpha lipoic acid (ALA)
Number of subjects: 20
Study 36069950 — intervention group
Group type: COMPARATOR
Intervention: add-on placebo
Number of subjects: 20
Study 34256810 — intervention group
Group type: EXPERIMENTAL
Intervention: Psycho-education intervention delivered by village health team (VHT) members, including information education and communication materials (IEC) aimed at improving MHL.
Number of subjects: 840
Study 34256810 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving ministry of health COVID-19 information leaflets distributed by VHTs.
Number of subjects: 840